Medpace Holdings (MEDP) Total Current Liabilities (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Total Current Liabilities came in at $1.4 billion in Q2 2026, up 17.62% on a YoY basis from $1.2 billion in Q2 2025, and up 6.72% quarter-over-quarter from $1.3 billion in Q1 2026.
Analysis
Medpace Holdings (MEDP) Total Current Liabilities (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Total Current Liabilities for 12 consecutive years, with $1.4 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Current Liabilities rose 17.62% year-over-year to $1.4 billion; the trailing twelve-month figure through Jun 2026 stood at $1.4 billion (up 17.62% YoY), and the FY2025 full-year result was $1.3 billion, up 21.66% from the prior year.
- Total Current Liabilities advanced to $1.4 billion in Q2 2026 per MEDP's latest filing, from $1.3 billion in the prior quarter.
- Across five years, Total Current Liabilities topped out at $1.4 billion in Q2 2026 and bottomed at $579.4 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $1.0 billion across 5 years, with a median of $974.9 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Total Current Liabilities surged 85.98% in 2022, then declined 3.02% in 2023.
- Over 5 years, Total Current Liabilities stood at $803.5 million in 2022, then gained by 15.14% to $925.1 million in 2023, then climbed by 19.39% to $1.1 billion in 2024, then climbed by 21.66% to $1.3 billion in 2025, then rose by 6.82% to $1.4 billion in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $1.4 billion, $1.3 billion, and $1.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 8.82 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 1.44 Bn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 3.93 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 1.13 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 963.70 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 363.19 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 72.74 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 18.73 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 4.76 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 1.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.44 Bn |
| Mar 31, 2026 | 1.35 Bn |
| Dec 31, 2025 | 1.34 Bn |
| Sep 30, 2025 | 1.28 Bn |
| Jun 30, 2025 | 1.22 Bn |
| Mar 31, 2025 | 1.12 Bn |
| Dec 31, 2024 | 1.10 Bn |
| Sep 30, 2024 | 1.04 Bn |
| Jun 30, 2024 | 993.09 Mn |
| Mar 31, 2024 | 956.65 Mn |
| Dec 31, 2023 | 925.13 Mn |
| Sep 30, 2023 | 848.52 Mn |
| Jun 30, 2023 | 852.44 Mn |
| Mar 31, 2023 | 881.89 Mn |
| Dec 31, 2022 | 803.47 Mn |
| Sep 30, 2022 | 820.87 Mn |
| Jun 30, 2022 | 878.96 Mn |
| Mar 31, 2022 | 579.43 Mn |
| Dec 31, 2021 | 557.22 Mn |
| Sep 30, 2021 | 517.18 Mn |